HCMR Re-Imaging Study

Not yet recruitingOBSERVATIONAL
Enrollment

314

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

July 31, 2026

Conditions
Hypertrophic Cardiomyopathy (HCM)
Interventions
OTHER

None - observational study

None - observational study

Trial Locations (8)

22903

University of Virginia, Charlottesville

44195

Cleveland Clinic, Cleveland

48109

University of Michigan, Ann Arbor

60208

Northwestern, Evanston

02115

Brigham & Women's Hospital, Boston

02155

Tufts Medical Center, Medford

B15 2GW

University Hospitals Birmingham NHS Foundation Trust, Birmingham

E2 9JX

London Chest Hospital, London

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

Tufts Medical Center

OTHER

collaborator

Northwestern University

OTHER

collaborator

University of Michigan

OTHER

collaborator

The Cleveland Clinic

OTHER

collaborator

University Hospital Birmingham NHS Foundation Trust

OTHER

collaborator

Glenfield Hospital, Leicester

OTHER

collaborator

London Chest Hospital

UNKNOWN

collaborator

Cytokinetics

INDUSTRY

collaborator

Toronto General Hospital

OTHER

lead

Christopher Kramer

OTHER

NCT07054073 - HCMR Re-Imaging Study | Biotech Hunter | Biotech Hunter